Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BORTEZOMIB for Transplant rejection: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 145 adverse event reports in the FDA FAERS database where BORTEZOMIB was used for Transplant rejection.

Most Reported Side Effects for BORTEZOMIB

Side Effect Reports % Deaths Hosp.
Plasma cell myeloma 6,683 14.0% 1,185 694
Off label use 4,754 10.0% 956 1,101
Neuropathy peripheral 4,067 8.5% 226 488
Drug ineffective 2,730 5.7% 565 532
Diarrhoea 2,244 4.7% 296 944
Thrombocytopenia 2,082 4.4% 391 716
Death 2,025 4.2% 2,018 251
Pneumonia 2,020 4.2% 519 1,308
Fatigue 1,757 3.7% 188 446
Neutropenia 1,530 3.2% 247 428
Anaemia 1,486 3.1% 306 593
Disease progression 1,399 2.9% 355 233
Pyrexia 1,384 2.9% 204 854
Intentional product use issue 1,361 2.9% 250 126
Nausea 1,318 2.8% 160 501

Other Indications for BORTEZOMIB

Plasma cell myeloma (31,567) Product used for unknown indication (6,690) Amyloidosis (1,044) Primary amyloidosis (905) Plasma cell myeloma refractory (848) Mantle cell lymphoma (630) Plasma cell leukaemia (458) Waldenstrom's macroglobulinaemia (425) Chemotherapy (298) Plasmablastic lymphoma (216)

Other Drugs Used for Transplant rejection

METHYLPREDNISOLONE (968) RITUXIMAB (615) TACROLIMUS (477) HUMAN IMMUNOGLOBULIN G (327) PREDNISONE (300) MYCOPHENOLATE MOFETIL (297) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (273) ECULIZUMAB (176) THYMOCYTE IMMUNE GLOBULIN NOS (173) PREDNISOLONE (145)

Related Pages

BORTEZOMIB Full Profile All Transplant rejection Drugs BORTEZOMIB Demographics BORTEZOMIB Timeline